These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Biomarkers of vulnerable plaque: the missing link with ischemia. Muller O; Barbato E; De Bruyne B; Bartunek J Biomark Med; 2010 Jun; 4(3):375-83. PubMed ID: 20550471 [TBL] [Abstract][Full Text] [Related]
23. [Redefinition of myocardial infarction--relevance of biomarkers]. Weber M; Hamm C Herz; 2008 Mar; 33(2):115-21. PubMed ID: 18344030 [TBL] [Abstract][Full Text] [Related]
24. Prognostic values of various markers in evaluation of patients with chest pain. David DS Am J Cardiol; 2009 May; 103(9):1329-30. PubMed ID: 19406283 [No Abstract] [Full Text] [Related]
25. Activated factor XII type A and B-type natriuretic peptide are complementary and incremental predictors of mortality in patients following admission with acute coronary syndrome. Pönitz V; Brügger-Andersen T; Pritchard D; Grundt H; Staines H; Nilsen DW; Blood Coagul Fibrinolysis; 2009 Dec; 20(8):652-60. PubMed ID: 19809305 [TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome. Hjortshøj S; Kristensen SR; Ravkilde J Am J Emerg Med; 2010 Feb; 28(2):170-6. PubMed ID: 20159386 [TBL] [Abstract][Full Text] [Related]
27. Ischemia-modified albumin in differential diagnosis of acute coronary syndrome without ST elevation and unstable angina pectoris. Wudkowska A; Goch J; Goch A Kardiol Pol; 2010 Apr; 68(4):431-7. PubMed ID: 20425705 [TBL] [Abstract][Full Text] [Related]
28. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657 [TBL] [Abstract][Full Text] [Related]
36. B-type natriuretic peptide-a CPK for heart-failure and beyond (ischemia)? Arora V; Bhandari S Indian Heart J; 2006; 58(2):90-2. PubMed ID: 18989049 [No Abstract] [Full Text] [Related]
37. Cardiac biomakers for the evaluation of acute coronary syndrome. Rodriguez-Ospina LF; Rosales-Alvarez CP; Lopez-Mas A Bol Asoc Med P R; 2009; 101(4):15-22. PubMed ID: 20853555 [TBL] [Abstract][Full Text] [Related]
38. Ischaemia modified albumin cannot be used for rapid exclusion of acute coronary syndrome. Lin RM; Fatovich DM; Grasko JM; Vasikaran SD Emerg Med J; 2010 Sep; 27(9):668-71. PubMed ID: 20466824 [TBL] [Abstract][Full Text] [Related]
39. Biomarkers in acute cardiovascular disease. Howie-Esquivel J; White M J Cardiovasc Nurs; 2008; 23(2):124-31. PubMed ID: 18382255 [TBL] [Abstract][Full Text] [Related]
40. Platelet glycoprotein VI (GPVI) for early identification of acute coronary syndrome in patients with chest pain. Bigalke B; Haap M; Stellos K; Geisler T; Seizer P; Kremmer E; Overkamp D; Gawaz M Thromb Res; 2010 May; 125(5):e184-9. PubMed ID: 20122713 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]